Right to Try Gives Terminal Patients Access to Potentially Life-Saving Treatments Without FDA Permission

Released Friday, 26th April 2019
Good episode? Give it some love!
In May of 2018, President Donald Trump signed a new law allowing patients with life-threatening conditions to access experimental medications without obtaining FDA approval.

In our latest podcast, Reason's Zach Weissmueller sits down with Christina Sandefur, executive vice president of the Arizona-based Goldwater Institute, which played a key role in getting the law passed in 41 states before it arrived on the president's desk. 

For more on the topic, watch Weissmueller's video documentary on subject. In this conversation, he and Sandefur delve deeper into the details of the new Right to Try law, why it matters, how it got it passed, some criticisms of the legislation, and what more needs to be done to bring down prescription drug costs and spur innovation.

Audio production by Ian Keyser.

Episode Reviews

This episode hasn't been reviewed yet. You can add a review to show others what you thought.

This podcast, its content, and its artwork are not owned by, affiliated with, or endorsed by Podchaser.
Rate Episode

Share This Episode

Recommendation sent

Join Podchaser to...

  • Rate podcasts and episodes
  • Follow podcasts and creators
  • Create podcast and episode lists
  • & much more

Episode Details

52m 14s

Episode Tags

Do you host or manage this podcast?
Claim and edit this page to your liking.